有或无前感染史的三剂疫苗接种医护人员感染奥密克戎后的免疫反应 - Suppr

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.

作者信息

Blom Kim, Marking Ulrika, Havervall Sebastian, Norin Nina Greilert, Gordon Max, García Marina, Tecleab Teghesti, Christ Wanda, Forsell Mattias, Phillipson Mia, Nilsson Peter, Mangsbo Sara, Hober Sophia, Åberg Mikael, Klingström Jonas, Thålin Charlotte

机构信息

Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, 182 88 Stockholm, Sweden; Public Health Agency of Sweden, Stockholm, Sweden.

Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, 182 88 Stockholm, Sweden.

出版信息

Lancet Infect Dis. 2022 Jul;22(7):943-945. doi: 10.1016/S1473-3099(22)00362-0. Epub 2022 Jun 9.

DOI:10.1016/S1473-3099(22)00362-0

PMID:35691303

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9183210/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d8/9183210/641c872d5155/gr1_lrg.jpg

相似文献

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.

Lancet Infect Dis. 2022 Jul;22(7):943-945. doi: 10.1016/S1473-3099(22)00362-0. Epub 2022 Jun 9.

Omicron Outbreak at a Private Gathering in the Faroe Islands, Infecting 21 of 33 Triple-Vaccinated Healthcare Workers.

Clin Infect Dis. 2022 Sep 14;75(5):893-896. doi: 10.1093/cid/ciac089.

Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2.

J Infect. 2022 Nov;85(5):e125-e126. doi: 10.1016/j.jinf.2022.08.023. Epub 2022 Aug 27.

[Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].

Mikrobiyol Bul. 2022 Jul;56(3):480-492. doi: 10.5578/mb.20229708.

BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality.

Nat Microbiol. 2022 Jun;7(6):909-917. doi: 10.1038/s41564-022-01123-x. Epub 2022 May 16.

Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.

mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.

Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.

JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.

Nat Med. 2022 Mar;28(3):496-503. doi: 10.1038/s41591-022-01715-4. Epub 2022 Jan 28.

Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals.

JAMA Netw Open. 2022 Apr 1;5(4):e2210871. doi: 10.1001/jamanetworkopen.2022.10871.

SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.

J Infect Dis. 2021 Feb 24;223(4):589-599. doi: 10.1093/infdis/jiaa737.

引用本文的文献

Immune Imprinting, Non-Durable Hybrid Immunity, and Hybrid Immune Damping Following SARS-CoV-2 Primary Vaccination with BNT162b2 and Boosting with mRNA-1273.

Vaccines (Basel). 2025 Mar 13;13(3):310. doi: 10.3390/vaccines13030310.

Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population.

J Infect Dis. 2025 Apr 15;231(4):921-930. doi: 10.1093/infdis/jiae622.

Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera.

Vaccines (Basel). 2024 Aug 13;12(8):914. doi: 10.3390/vaccines12080914.

Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment.

Pathog Immun. 2024 Aug 15;9(2):58-78. doi: 10.20411/pai.v9i2.715. eCollection 2024.

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.

Front Immunol. 2024 May 15;15:1372193. doi: 10.3389/fimmu.2024.1372193. eCollection 2024.

Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.

Front Immunol. 2024 Mar 15;15:1346749. doi: 10.3389/fimmu.2024.1346749. eCollection 2024.

Longitudinal antibody dynamics after COVID-19 vaccine boosters based on prior infection status and booster doses.

Sci Rep. 2024 Feb 25;14(1):4564. doi: 10.1038/s41598-024-55245-9.

A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates.

Vaccines (Basel). 2024 Jan 27;12(2):132. doi: 10.3390/vaccines12020132.

Long-Term Analyses of SARS-CoV-2 Humoral and T Cell Responses and Breakthrough SARS-CoV-2 Infections after Two Doses of BNT162b2 Followed by mRNA-1273 and Bivalent Omicron-Adapted BNT162b2 Vaccines: A Prospective Study over 2 Years in Non-Immunocompromised Individuals.

Vaccines (Basel). 2023 Dec 10;11(12):1835. doi: 10.3390/vaccines11121835.

Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition.

iScience. 2023 Oct 27;26(12):108336. doi: 10.1016/j.isci.2023.108336. eCollection 2023 Dec 15.

本文引用的文献

Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.

Nat Immunol. 2022 Jun;23(6):940-946. doi: 10.1038/s41590-022-01212-3. Epub 2022 May 9.

Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.

Clin Transl Immunology. 2022 Apr 18;11(4):e1388. doi: 10.1002/cti2.1388. eCollection 2022.

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.

N Engl J Med. 2022 Mar 17;386(11):1088-1091. doi: 10.1056/NEJMc2119912. Epub 2022 Jan 26.

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Lancet. 2022 Jan 15;399(10321):234-236. doi: 10.1016/S0140-6736(21)02844-0. Epub 2021 Dec 20.

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.

Nat Commun. 2020 Oct 8;11(1):5064. doi: 10.1038/s41467-020-18848-0.

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.

Nat Biotechnol. 2020 Sep;38(9):1073-1078. doi: 10.1038/s41587-020-0631-z. Epub 2020 Jul 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献